Board of Directors

Pictured from left to right:


Phillip Austin - Director

Partner, Anterra Capital


John Sorenson, Ph.D. - Director and CEO/President of Vestaron

Former President, Syngenta Biotechnology


Elin Miller - Vice Chairman


Keith Gillard - Chairman of the Board of Directors

General Partner, Pangaea Ventures, Ltd.


Ronald Meeusen - Director

Managing Partner, Cultivian Sandbox Ventures


James Schultz - Director

Managing Partner, Open Prairie Ventures


Not shown in the picture:


Mark Wong - Director

Serial energy and agriculture entrepreneur

Corporate Officers

Robert M. Kennedy, Ph.D. – CSO

With over 25 years of research management experience, Bob leads Vestaron’s molecular biology and chemistry development teams. Management positions in Fortune 500 companies (Pfizer), academic appointments (Columbia, Michigan) and start-ups add to the leadership and technical experience he brings to Vestaron’s Research and Development success.



Nancy K. Newman – CFO

25 years of finance, tax, treasury and systems experience with Fortune 500 and start-up companies, leading finance efforts in formation and oversight of global operations as well as leadership in developing corporate financing strategies. Her experience includes Pharmacia/Upjohn, Pfizer, Interpublic Group of Companies, A.M. Todd Group and several early stage companies.



Andy Renz – Vice President of Business Development

Over 15 years of industry experience in agricultural innovation and business development. Andy held management positions at BASF, was Vice President of Business Development at Benson Hill Biosystems, and is on the industry advisory board of ag tech start-up’s, incubators and conferences. He has a strong network in agricultural solutions and is an expert in international negotiations.

©2015 Vestaron Corporation

All Rights Reserved. Always Read and Follow Label Directions.